Intensity Therapeutics, Inc. (private) announced that President and CEO Lewis H. Bender will participate in a panel discussion on Biotech Innovation in cancer at the Wharton Innovation Summit at 3:30PM on Wednesday, April 30, 2014. The Summit is sponsored by the Wharton Club and is being held at the FHI 360 Conference Center located at 1825 Connecticut Avenue NW in Washington DC. Mr. Bender will join leading cancer scientists to discuss “Disease Prevention and Cancer Therapeutics”. Mr. Bender will be available for meetings with potential collaboration partners and investors participating at the conference before and after his panel.